A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE

被引：7

作者：

Descamps, Olivier S. ^{[1
,2
]}

Cooney, Marie Therese ^{[3
]}

De Backer, Guy ^{[4
]}

Graham, Ian ^{[3
]}

机构：

[1] Hop Jolimont, Ctr Rech Med Jolimont, B-7100 Haine St Paul, Belgium

[2] Hop Jolimont, Dept Med Interne, B-7100 Haine St Paul, Belgium

[3] Adelaide & Meath Hosp, Dept Cardiol, Dublin 24, Ireland

[4] Ghent Univ Hosp, Dept Cardiol, Ghent, Belgium

来源：

ATHEROSCLEROSIS | 2012年 / 222卷 / 02期

关键词：

SCORE; Cardiovascular risk; Risk assessment; Prevention; HDL cholesterol; Guidelines; GUIDELINES; DISEASE;

D O I：

10.1016/j.atherosclerosis.2012.03.035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The 2011 ESC-EAS guidelines on the management of dyslipidaemias use four separate charts to illustrate the impact of differing HDL cholesterol levels on risk of cardiovascular disease. We developed an easy way to calculate the effects of differing HDL-C levels on risk by deriving HDL and sex specific multipliers and applying these to various reference charts. Of three strategies explored, one based on a low HDL (0.8 mmol/l) reference chart was the simplest and was acceptably accurate. Such an approach simplifies risk estimation by avoiding the need for multiple charts. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

引用

页码：564 / 566

页数：3

共 50 条

[1] Impact of Using Different SCORE Tables for Estimating Cardiovascular Risk
Brotons, Carlos
Moral, Irene
Soriano, Nuria
Cuixart, Lluis
Osorio, Dimelza
Bottaro, David
Puig, Mireia
Joaniquet, Xavier
Marcos, Albert
Casasa, Albert
REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (02): : 94 - 100
[2] Unanswered questions in including HDL-cholesterol in the cardiovascular risk estimation. Is time still on our side?
Langlois, Michel R.
Delanghe, Joris R.
De Buyzere, Marc
Rietzschel, Ernst
De Bacquer, Dirk
ATHEROSCLEROSIS, 2013, 226 (01) : 296 - 298
[3] HDL cholesterol and cardiovascular risk
Ghali, William A.
Rodondi, Nicolas
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338
[4] Estimation of cardiovascular risk based on total cholesterol versus total cholesterol/high-density lipoprotein within different ethnic groups: The HELIUS study
Perini, Wilco
Snijder, Marieke B.
Peters, Ron J.
Kunst, Anton E.
van Valkengoed, Irene G.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (17) : 1888 - 1896
[5] Dissociating HDL cholesterol from cardiovascular risk
Hausenloy, Derek J.
Opie, Lionel
Yellon, Derek M.
LANCET, 2010, 376 (9738) : 305 - 306
[6] Clinical, biochemical profile and atherosclerotic cardiovascular risk score (ASCVD) in patients with high HDL cholesterol
Mallya, Raksha Udupi
Vidyasagar, Sudha
Varashree, B. S.
Sukumar, Cynthia Amrutha
IRISH JOURNAL OF MEDICAL SCIENCE, 2025, : 537 - 544
[7] How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators
Cooney, Marie Therese
Dudina, Alexandra
De Bacquer, Dirk
Fitzgerald, Anthony
Conroy, Ronan
Sans, Susana
Menotti, Alessandro
De Backer, Guy
Jousilahti, Pekka
Keil, Ulrich
Thomsen, Troels
Whincup, Peter
Graham, Ian
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (03): : 304 - 314
[8] Discordance analyses comparing LDL cholesterol, Non-HDL cholesterol, and apolipoprotein B for cardiovascular risk estimation
Johannesen, Camilla Ditlev Lindhardt
Mortensen, Martin Bodtker
Nordestgaard, Borge Gronne
Langsted, Anne
ATHEROSCLEROSIS, 2025, 403
[9] Improving the prediction of cardiovascular risk: Interaction between LDL and HDL cholesterol
Grover, SA
Dorais, M
Coupal, L
EPIDEMIOLOGY, 2003, 14 (03) : 315 - 320
[10] Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index
Gomez-Vaquero, Carmen
Robustillo, Montserrat
Narvaez, Javier
Rodriguez-Moreno, Jesus
Gonzalez-Juanatey, Carlos
Llorca, Javier
Miquel Nolla, Joan
Angel Gonzalez-Gay, Miguel
CLINICAL RHEUMATOLOGY, 2012, 31 (01) : 35 - 39

← 1 2 3 4 5 →